CAMBRIDGE, Mass.--Millennium Pharmaceuticals here has named Kenneth Conway to the position of president of predictive medicine, where he will lead a new initiative to develop genomics-derived products and services to predict, diagnose and monitor disease and drug response. Conway was previously senior vice-president and general manager of immuno diagnostics for Chiron Diagnostics, and had held several other executive positions with that company.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.